Compositions comprising theanine, magnolia, and phellodendron
AssigneeNutramax Laboratories, Inc.
InventorsTodd Henderson, David Griffin, David Bledsoe
Life of this patent
Estimating the term…
Abstract
An anxiolytic composition formulated for oral administration to a mammal includes a synergistic combination of L-theanine, at least one of magnolia and an extract of magnolia, and at least one of phellodendron and an extract of phellodendron. The composition may include a combination of an extract of Magnolia officinalis and a extract of Phellodendron amurense. The synergistic combination may provide an anxiolytic change in a release pattern of one or more brain neurotransmitters, such as glutamate and/or γ-aminobutyric acid (GABA).
Claims20
An anxiolytic composition, comprising a combination of L-theanine, at least one of magnolia and an extract of magnolia, and at least one of phellodendron and an extract of phellodendron in amounts synergistically effective to modulate one or more neurotransmitters.
A method for reducing, ameliorating, or treating symptoms of anxiety, comprising administration of a combination of L-theanine, at least one of magnolia and an extract of magnolia, and at least one of phellodendron and an extract of phellodendron in amounts synergistically effective to modulate one or more neurotransmitters.
Dependencies are inferred from the claim text.